CATIE and CUtLASS: can we handle the truth?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18310570.
- Also identified by DOI 10.1192/bjp.bp.107.037218.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two large, non-commercial clinical trials comparing first- and second-generation antipsychotic drugs for people with chronic schizophrenia in the US and UK have shown unexpected results. In general, the newer drugs were no more effective or better tolerated than the older drugs. Clozapine outperformed other second-generation drugs. The implications are considered.
Medical subject headings
- Antipsychotic Agents
- Schizophrenia